Ludwig Center at MSK
Ludwig Institute for Cancer Research
United States of America
I am an Assistant Attending at Memorial Sloan-Kettering Cancer Center with a shared appointment to the Melanoma-Sarcoma Service and the Immunotherapeutics Clinical Core. My laboratory interests are focused on two areas: a) investigating novel combinations of immunotherapies with targeted inhibitors; and b) exploring immune-based biomarkers in clinical studies of novel immunotherapies.
Immunotherapeutics, biomarkers, cancer biology
Ribas, Antoni, et al. "Hepatotoxicity with combination of vemurafenib and ipilimumab." New England Journal of Medicine 368.14 (2013): 1365-1366.
Postow, Michael A., et al. "Immunologic correlates of the abscopal effect in a patient with melanoma." New England Journal of Medicine 366.10 (2012): 925-931.
Wolchok, Jedd D., et al. "Nivolumab plus ipilimumab in advanced melanoma." New England Journal of Medicine 369.2 (2013): 122-133.